Clinical Implication of FDG-PET/CT in Monitoring Disease Activity in Large-Vessel Giant Cell Arteritis Linked With Secondary Polymyalgia Rheumatica

Case Reports in Internal Medicine
doi 10.5430/crim.v1n1p6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciedu Press

Related search

Giant-Cell Arteritis and Polymyalgia Rheumatica

Annals of Internal Medicine
Internal MedicineMedicine
2003English

Hypothyroidism in Polymyalgia Rheumatica and Giant Cell Arteritis.

BMJ
1990English

ESR in Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1983English

Treatment of Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Various Forms of 18f-FDG PET and PET/CT Findings in Patients With Polymyalgia Rheumatica

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2015English

Infliximab Doesn't Work in Giant Cell Arteritis or Polymyalgia Rheumatica

BMJ
2007English

Azathioprine in Giant Cell Arteritis/Polymyalgia Rheumatica: A Double-Blind Study.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1986English

Associations Between Polymyalgia Rheumatica and Giant Cell Arteritis and 12 Cardiovascular Diseases

Heart
Cardiovascular MedicineCardiology
2016English

Large Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?

Arthritis Care and Research
Rheumatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy